BAL Lazio

HTA

HTA – Risorse

Pubblicato lunedì 5 maggio 2014

Risorse generali e reti internazionali

European network for Health Technology Assessment (EUNETHTA)
Health Technology Assessment Database (Cochrane)
Health Technology Assessment international (HTAi)
International Information Network on New and Emerging Health Technologies (EuroScan)
International Network of Agencies of Health Technology Assessment (INAHTA)

EUROPA

Italia
Agenzia nazionale per i servizi sanitari regionali (Age.Na.S.)
Società Italiana di Health Technology Assessment (SIHTA)

Austria
Ludwig Boltzmann Institut für Health Technology Assessment (LBI of HTA)

Belgio
Belgian Federal Health Care Knowledge Centre (KCE)

Danimarca
Danish Institute for Health Services Research (DSI)

Finlandia
Finnish Office for Health Technology Assessment (FinOHTA)

Francia
Comité d´Evaluation et de Diffusion des Innovations Technologiques (CEDIT)
Haute Autorité de Santé (HAS)

Germania
German Agency for HTA at the German Institute for Medical Documentation and Information (DAHTA @DIMDI)
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)

Lettonia
Health Statistics and Medical Technologies State Agency (VSMTVA)

Lituania
State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania (VASPVT)

Norvegia
Norwegian Knowledge Centre for the Health Services (NOKC)

Paesi Bassi
Gezondheidsraad (GR)
The Medical and Health Research Council of The Netherlands (ZonMw)

Polonia
Agency for Health Technology Assessment in Poland (AHTAPol)

Regno Unito
Centre for Reviews and Dissemination (CRD)
Institute of Applied Health Sciences (IAHS)
National Institute for Health Research Health Technology Assessment Programme
Quality Improvement Scotland (NHS QIS)

Spagna
Agencia de Evaluación de Tecnologias Sanitarias (AETS)
Andalusian Agency for Health Technology Assessment (AETSA)
Galician Agency for Health Technology Assessment (AVALIA-T)
Catalan Agency for Health Technology Assessment and Research (CAHTA)
Basque Office for Health Technology Assessment (OSTEBA)

Svezia
Swedish Council on Technology Assessment in Health Care (SBU)

Svizzera
Medical Technology Unit – Swiss Federal Office of Public Health (MTU-SFOPH)

RESTO DEL MONDO

Argentina
Institute for Clinical Effectiveness and Health Policy (IECS)

Australia
Adelaide Health Technology Assessment (AHTA)
Medical Services Advisory Committee (MSAC)

Brasile
Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Ciência e Tecnologia (DECIT-CGATS)

Canada
Agence d´Évaluation des Technologies et des Modes d´Intervention en Santé (AETMIS)
Canadian Agency for Drugs and Technologies in Health (CADTH)
Institute of Health Economics (IHE)

Malesia
Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS)

Messico
Centro Nacional de Excelencia Tecnológica en Salud (CENETEC)

Nuova Zelanda
Health Services Assessment Collaboration (HSAC)

Taiwan
Center for Drug Evaluation (CDE)

USA
Agency for Healthcare Research and Quality (AHRQ)

Archiviato in ,

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Accedi agli articoli

Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
Sparano AJ et al.
The New England Journal of Medicine

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors
Arbyn M et al.
Cochrane Database of Systematic Reviews

Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease
Di Domenicantonio et al.
Clinical Epidemiology

Aspirin or Rivaroxaban for VTE prophylaxis after hip or knee arthroplasty
Anderson DR et al.
The New England Journal of Medicine

Incremental effects of antihypertensive drugs: instrumental variable analysis
Markovitz AA et al.
BMJ

Upright versus lying down position in second stage of labour in nulliparous women with low dose epidural: BUMPES randomised controlled trial
The Epidural and Position Trial Collaborative Group
BMJ

What evidence affects clinical practice? An analysis of Evidence-Based Medicine commentaries
Coombs C et al.
Evidence-Based Medicine

Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
Ferreira RM et al.
Gut

Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal WomenUS Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force
JAMA

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients.
Antifibrinolytic Trials Collaboration
Lancet

Prevalence of asthma-like symptoms with ageing
Jarvis D et al.
Thorax

Una finestra sull’open access

  • BMC Family Practice
  • BMC Medical Education
  • BMC Nursing
  • BMJ Open
  • PLOS Medicine

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.